Other Headlines

Sentence and restitution required.
The DOTmed 100 company has a long tradition in medical technology.
Joint venture agreement with Japan's M-Cast, Inc., a subsidiary of leasing giant Mitsubishi UFJ Leasing and Finance.
RAND study confirms patients getting inaccurate information on physicians.
New KLAS report looks at smart pump adoption trends and the customer satisfaction gap among some products.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

CBO Releases Reconciliation Act Numbers Coverage in Senate Bill, Reconciliation costs $940 billion, reduces deficit by $138 billion.

ECR Video Profile: Dunlee, Philips Healthcare David Kuehn of Dunlee presents the company's two new products.

Health Care Vote May Come This Weekend Weekend vote is a possibility according to House Majority Leader.

Imaging 100 Preview: The Importance of Banding Together During Health Care Reform Imaging 100 speakers will focus on important health care reform issues.

Congressmen Introduce Bill for Electronic Health Record Interoperability While reform inches along, other legislation progresses.

ECR 2010 Video Profile: Barco DOTmed News stopped by Barco's booth to check out their upcoming medical tablets (developed by FIMI, Barco's recent acquisition) and their latest clinical displays that bring DICOM-compliant viewing outside of the radiologist's office.

CCHIT Comments on ONC's EHR Interim Final Rule The certification organization for electronic health records in the U.S. points out problems in vagueness, complexity of criteria. Also, get a DOTmed exclusive update on CCHIT's testing status.

Health Care Reform Round-Up: More Maneuvers May Be Needed for Passage House leaders said to be considering "self-executing" rule for Senate bill passage.

MEDCAC to Meet on Prostate Determination CMS to review coverage decisions about radiation therapy April 21.

Michigan Legislature Sends Device Re-Use Bill to Governor Bill would prohibit reusing single-use devices.

GE CEO Jeffrey Immelt

Times Are Tough, GE's CEO Reports, But the Company Remains Confident

by Lynn Shapiro, Writer
New York --Jeffrey Immelt, GE's Chairman and CEO, told securities analysts and investors Tuesday that the company had lowered profit projections for its industrial businesses, including medical equipment, jet engines and power turbines.

While Immelt said he would not provide analysts with an earnings forecast for next year, he said that overall profit at the Fairfield, CT-based conglomerate is expected to drop in 2009 for a second consecutive year. GE was forced to reduce its earnings projections several times in 2008, and its shares plunged 52 percent, partly in response to GE's continual earnings downgrades.

Story Continues Below Advertisement
DOTmed Text Ad

Attend the IDN Spring Summit & Expo. Contact Josh at 859.523.5701

Network with Senior Healthcare Purchasing Executives and their GPO & Supplier Partners this April 20-22 in Orlando. Attend this "Reverse Expo" and make new business relationships. Visit our website now for more information.


"While 2008 has been a challenging year for the global economy and for many of our businesses, we still expect to earn over $18 billion and outperform the S&P industrials and financial sectors," Immelt said.

He told analysts that GE had navigated the credit crisis and recession better than its peers and would benefit next year from its services businesses and declining materials costs.

"I'd say the environment is toughest for people of my generation. It's the toughest we have ever seen," Immelt said.

He said GE's revenue, estimated to be $185 billion this year, would drop as much as 5 percent next year as the company reduces its finance division, which has been caught in the credit crunch.

However, he said the company had no plans to sell the finance unit--GE Capital-- since the division loans money to customers of GE's industrial products.

Immelt also said GE would keep its annual dividend of $1.24 per share next year.

GE shares climbed 97 cents, or 5.7 percent to $17.92 on the New York Stock exchange Tuesday after Immelt's presentation, slightly beating the Dow Jones Industrial Average.

On a more upbeat note, Immelt told analysts that the company is focused on "growing organic revenue, reducing costs and expanding margins....We expect our major equipment and services backlog to remain strong in 2009 and we will expand our industrial margins, which already compare favorably to our competitors'," Immelt said. He added, "We are committed to investing in innovation and technology even in these challenging times. We will maintain our $1 billion investment in executive development and training and we have allocated $6 billion for technology in 2009."

Immelt said that because of the company's long-term investment in clean energy and healthcare, GE is well positioned to support governments around the world as they invest in infrastructure. In fact, Immelt said on Tuesday that GE had received a $3 billion order for gas turbines in Iraq to support the country's power-generating capability.

"We have multiple drivers of growth in a downturn, including services, infrastructure and strong margins," Immelt said. "We are committed to our strategy of growing globally, driving innovation, developing partnerships and using our scale. We are confident that as the economy recovers, GE will return to its historical earnings growth rate," Immelt said.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED